Skip to main content
. 2021 Sep 9;8:1129–1145. doi: 10.2147/JHC.S318865

Table 3.

Responses in 34 patients who received both sorafenib and 90Y

n
CT at week 16 Off-study 2 (5.8%)
PD 4 (11.8%)
PR 12 (35.3%)
SD 16 (47.1%)

Abbreviations: CT, computed tomography; PD, progression of disease; PR, partial response; SD, stable disease.